# Solitary Islet Transplantation for Type 1 Diabetes Mellitus Using Steroid Sparing Immunosuppression

> **NCT00006505** · PHASE2 · COMPLETED · sponsor: **National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)** · enrollment: 6 (actual)

## Conditions studied

- Diabetes Mellitus Type 1

## Interventions

- **DRUG:** Islet Transplantation

## Key facts

- **NCT ID:** NCT00006505
- **Lead sponsor:** National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
- **Sponsor class:** NIH
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2000-11-16
- **Primary completion:** 2002-06-30
- **Final completion:** 2020-04-21
- **Target enrollment:** 6 (ACTUAL)
- **Last updated:** 2021-04-20


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00006505

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00006505, "Solitary Islet Transplantation for Type 1 Diabetes Mellitus Using Steroid Sparing Immunosuppression". Retrieved via AI Analytics 2026-06-25 from https://api.ai-analytics.org/clinical/NCT00006505. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*